We are live on ! Find out more
1C

1623 Capital Portfolio holdings

AUM $173M
1-Year Est. Return 17.08%
This Fund
S&P 500
This Quarter Est. Return
-11.72%
1 Year Est. Return
+17.08%
3 Year Est. Return
+11.9%
5 Year Est. Return
10 Year Est. Return
AUM
$200M
AUM Growth
-$68.4M
Cap. Flow
-$41.1M
Cap. Flow %
-20.61%
Top 10 Hldgs %
50.88%
Holding
69
New
11
Increased
13
Reduced
12
Closed
18

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$4.5M
2
FDX icon
FedEx
FDX
+$3.29M
3
ETSY icon
Etsy
ETSY
+$2.08M
4
SPIR icon
Spire Global
SPIR
+$949K
5
TTD icon
Trade Desk
TTD
+$816K

Sector Composition

Rank Sector Weight
1 Technology 26.41%
2 Financials 15.91%
3 Consumer Discretionary 15.39%
4 Healthcare 10.83%
5 Real Estate 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBUX icon
26
Starbucks
SBUX
$120B
$3.73M 1.87%
41,000
MTCH icon
27
CALL
Match Group
MTCH
$9.19B
$1.96M 0.98%
18,000
-18,000
-50% -$1.99M
SPIR icon
28
Spire Global
SPIR
$444M
$1.16M 0.58%
68,948
+48,581
+239% +$949K
ETWO
29
DELISTED
E2open Parent Holdings
ETWO
$1.04M 0.52%
117,697
+11,201
+11% +$102K
SPLK
30
DELISTED
Splunk Inc
SPLK
$917K 0.46%
+6,171
New +$756K
EVBG
31
DELISTED
Everbridge, Inc. Common Stock
EVBG
$883K 0.44%
20,230
+1,933
+11% +$91.3K
IAS
32
DELISTED
Integral Ad Science
IAS
$804K 0.4%
58,231
+35,790
+159% +$610K
TDOC icon
33
Teladoc Health
TDOC
$1.22B
$725K 0.36%
+10,051
New +$724K
BMRN icon
34
BioMarin Pharmaceuticals
BMRN
$11.6B
$670K 0.34%
8,684
+1,312
+18% +$110K
FRSH icon
35
Freshworks
FRSH
$3.14B
$572K 0.29%
+31,898
New +$649K
PEN icon
36
Penumbra
PEN
$12.7B
$525K 0.26%
2,363
-118
-5% -$26.2K
NARI
37
DELISTED
Inari Medical, Inc. Common Stock
NARI
$512K 0.26%
5,647
-2,242
-28% -$184K
MYNA
38
DELISTED
Mynaric AG American Depository Shares
MYNA
$493K 0.25%
41,111
+26,111
+174% +$278K
SMAR
39
DELISTED
Smartsheet Inc.
SMAR
$436K 0.22%
7,957
-6,062
-43% -$346K
DXCM icon
40
DexCom
DXCM
$31.5B
$430K 0.22%
3,360
-1,296
-28% -$142K
VERV
41
DELISTED
Verve Therapeutics
VERV
$430K 0.22%
18,841
-966
-5% -$27.6K
CDLX icon
42
Cardlytics
CDLX
$21.7M
$424K 0.21%
+771
New +$466K
PODD icon
43
Insulet
PODD
$11.5B
$388K 0.19%
1,458
-851
-37% -$209K
QTRX icon
44
Quanterix
QTRX
$164M
$356K 0.18%
12,198
-4,264
-26% -$130K
TSHA icon
45
Taysha Gene Therapies
TSHA
$1.68B
$305K 0.15%
+46,763
New +$350K
NTLA icon
46
Intellia Therapeutics
NTLA
$1.49B
$299K 0.15%
+4,117
New +$349K
RARE icon
47
Ultragenyx Pharmaceutical
RARE
$2.45B
$294K 0.15%
4,044
-633
-14% -$44K
AMPS
48
DELISTED
Altus Power
AMPS
$289K 0.14%
+38,841
New +$305K
HLGN
49
DELISTED
Heliogen, Inc.
HLGN
$285K 0.14%
+1,551
New +$283K
ASAN icon
50
Asana
ASAN
$1.92B
$283K 0.14%
+7,072
New +$368K

Similar funds

1623 Capital's Q1 2022 Portfolio in Review

As of Q1 2022, 1623 Capital held 69 positions worth $200M, down 26% from $268M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

1623 Capital withdrew a net $41.1M in Q1 2022, closing 18 positions and reducing 12 holdings. Its most notable exit was iShares Core S&P Small-Cap ETF, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, 1623 Capital opened a new position in Splunk Inc worth $917K.

  • 1623 Capital's largest Q1 2022 buy was Splunk Inc: 6,171 shares worth $917K.
  • 1623 Capital added most to Visa in Q1 2022, an estimated $4.5M increase.
  • 1623 Capital's biggest Q1 2022 reduction was ServiceNow, cutting an estimated $2.19M.
  • 1623 Capital fully exited iShares Core S&P Small-Cap ETF in Q1 2022, selling an estimated $11.1M.
  • 1623 Capital's ten largest holdings make up 51% of its $200M portfolio in Q1 2022.
  • 1623 Capital opened 11 new positions and closed 18 in Q1 2022.
  • 1623 Capital's portfolio value fell 26% quarter-over-quarter to $200M.

Based on 1623 Capital's 13F filing for Q1 2022, filed 13 May 2022.